Name | Type | Posted | Actions |
|---|---|---|---|
APPENDIX F ARPA-H COST PROPOSAL SPREADSHEET (Other Transaction Teaming) - BIOGAMI.xlsx | XLSX | Mar 24, 2026 | |
APPENDIX D ARPA-H GANTT Chart Sample - BIOGAMI.xlsx | XLSX | Jan 30, 2026 | |
APPENDIX C ARPA-H Task Description Document (TDD) - BIOGAMI.docx | DOCX | Jan 30, 2026 | |
APPENDIX B FULL PROPOSAL FORMAT AND INSTRUCTIONS - BIOGAMI.docx | DOCX | Jan 30, 2026 | |
APPENDIX A SOLUTION SUMMARY FORMAT AND INSTRUCTIONS - BIOGAMI.docx | DOCX | Jan 30, 2026 | |
BIOGAMI_ISO_ARPA-H-SOL-26-149.pdf | Jan 30, 2026 | ||
APPENDIX F ARPA-H COST PROPOSAL SPREADSHEET (Other Transaction) - BIOGAMI.xlsx | XLSX | Jan 30, 2026 | |
APPENDIX I DANGEROUS GAIN OF FUNCTION ASSESSMENT - BIOGAMI.docx | DOCX | Jan 30, 2026 | |
APPENDIX H ARPA-H Security Attestation Form - BIOGAMI.docx | DOCX | Jan 30, 2026 | |
APPENDIX G ADMIN NATIONAL POLICY (Other Transaction) - BIOGAMI.docx | DOCX | Jan 30, 2026 | |
APPENDIX J ARPA-H Draft Other Transaction Agreement - BIOGAMI.docx | DOCX | Jan 30, 2026 | |
APPENDIX E DATA MANAGEMENT AND SHARING PLAN - BIOGAMI.docx | DOCX | Jan 30, 2026 |
BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI)
Contact and place of performance
The BIOGAMI Team
Washington, DC
USA
24 March 2026 Update: This update replaces the original cost proposal spreadsheet (Appendix F) with one that incorporates the ISO's multi-party teaming terminology. ________________________________________________________ All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the BIOGAMI Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor...
View moreThe Advanced Research Projects Agency for Health (ARPA-H), a component of the National Institutes of Health, issued Innovative Solutions Opening ARPA-H-SOL-26-149 to support the BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI) program. This solicitation is classified under NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology), and PSC AN13, HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT. There is no set-aside (NONE) assigned to this procurement. The agency anticipates awarding multiple Other Transaction (OT) agreements to address the program's research and development goals.
The BIOGAMI program focuses on biotechnological interventions and modulation strategies for protein aggregation, with the primary place of performance located in Washington, DC. Interested parties must submit materials following the specific formats and instructions provided in the 12 available attachments, which include templates for solution summaries, full proposals, task description documents, and GANTT charts. Recent updates to the solicitation include a revised cost proposal spreadsheet designed to incorporate multi-party teaming terminology.
Submissions for this solicitation are due by April 15, 2026. The BIOGAMI Team serves as the primary point of contact for this notice. Proposals and inquiries are processed according to the instructions in the Innovative Solutions Opening and its ten associated appendices, which provide the framework for the anticipated Other Transaction agreements.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.